Back

Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Models to predict unfavourable outcomes in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Vasileios Anastasiou

Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Risk prediction models for incident heart failure: a systematic review and meta-analysis
Mr J. Navarro (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
A flexible, calibrated transformer-based risk model for prediction of clinical outcomes in patients with heart failure; an open cohort study using linked UK EHR
Doctor S. Rao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic value of reticulocyte production ability in patients with chronic heart failure
Doctor M. Nakao (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Explainable machine learning and multi-modal data for predicting readmission in patients with heart failure
Ms R. Chae (US)
Abstract Slides Video
Presentation thumbnail
Development and validation of a predicting model for risk of mortality in heart failure patients with mildly reduced ejection fraction post discharge
Professor Y. Zhu (Xiangtan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Models to predict unfavourable outcomes in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Genotype-driven prognostication in dilated cardiomyopathy
thumbnail
Congress Presentation
From genes to outcomes: the prognostic role of genetic mutations in dilated cardiomyopathy
thumbnail
Congress Presentation
Overlap in scarring phenotypes between non-dilated left ventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: Implications for prognostic stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources